Orphazyme A/S (OZYMF)
USD 90.0
(0.0%)
USD 90.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -26.04 Million DKK | 76.45% |
| 2022 | -110.59 Million USD | -15.49% |
| 2021 | -95.75 Million DKK | 8.01% |
| 2020 | -104.09 Million DKK | -105.32% |
| 2019 | -50.69 Million DKK | 77.92% |
| 2018 | -229.6 Million DKK | -81.93% |
| 2017 | -126.2 Million DKK | -117.84% |
| 2016 | -57.93 Million DKK | -21.42% |
| 2015 | -47.71 Million DKK | -46.4% |
| 2014 | -32.59 Million DKK | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 264.81 Thousand USD | -99.9% |
| 2023 FY | -26.04 Million DKK | 76.45% |
| 2023 Q2 | -1.86 Million USD | 0.0% |
| 2023 Q4 | -1.96 Million USD | 0.0% |
| 2022 FY | -110.59 Million USD | -15.49% |
| 2022 Q4 | -5.25 Million USD | 0.0% |
| 2022 Q2 | -11.63 Million USD | 0.0% |
| 2021 FY | -95.75 Million DKK | 8.01% |
| 2020 FY | -104.09 Million DKK | -105.32% |
| 2019 FY | -50.69 Million DKK | 77.92% |
| 2018 FY | -229.6 Million DKK | -81.93% |
| 2017 FY | -126.2 Million DKK | -117.84% |
| 2016 FY | -57.93 Million DKK | -21.42% |
| 2015 FY | -47.71 Million DKK | -46.4% |
| 2014 FY | -32.59 Million DKK | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Evofem Biosciences, Inc. | 52.97 Million USD | 149.167% |
| Arch Therapeutics, Inc. | -6.98 Million USD | -273.029% |
| CSL Limited | 2.64 Billion USD | 100.986% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 139.992% |
| Regen BioPharma, Inc. | 1.02 Million USD | 2644.973% |
| BioStem Technologies, Inc. | -8.48 Million USD | -207.062% |
| Capstone Therapeutics Corp. | -3.81 Million USD | -582.063% |
| Qrons Inc. | -789.34 Thousand USD | -3199.943% |
| Nascent Biotech, Inc. | -2.08 Million USD | -1147.7% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | 58.389% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | -229.592% |
| Skye Bioscience, Inc. | -37.64 Million USD | 30.806% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -6169.39% |
| Rebus Holdings, Inc. | -1.02 Million USD | -2453.725% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | -64.119% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -1850.531% |
| Genscript Biotech Corporation | -95.47 Million USD | 72.718% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -4018.866% |
| Adynxx, Inc. | - USD | Infinity% |
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | 65.252% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | -296.1% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -9427.363% |
| SQZ Biotechnologies Company | -79.46 Million USD | 67.22% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | -800.569% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -1330.794% |
| Mesoblast Limited | -87.95 Million USD | 70.385% |
| Marizyme, Inc. | -65.34 Million USD | 60.139% |
| Genus plc | 7.9 Million USD | 429.722% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | -139.154% |
| Pharming Group N.V. | -10.54 Million USD | -146.947% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | -1100.472% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | -602.058% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | -194.527% |
| ContraFect Corporation | -65.15 Million USD | 60.02% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | -433.108% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -1407.883% |
| IMV Inc. | -36.48 Million USD | 28.608% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | -223.189% |
| MultiCell Technologies, Inc. | -380.07 USD | -6853374.36% |
| ONE Bio Corp. | 8.67 Million USD | 400.209% |
| Accustem Sciences Inc. | -3.74 Million USD | -595.277% |
| RVL Pharmaceuticals plc | -51.69 Million USD | 49.609% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -1.26 Million USD | -1955.663% |
| Q BioMed Inc. | -2.05 Million USD | -1169.338% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | -597.777% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | -994.054% |
| Biomind Labs Inc. | -1.21 Million USD | -2045.071% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | 56.387% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | -739.779% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -1236.31% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -173831.624% |
| Curative Biotechnology, Inc. | -5.81 Million USD | -347.771% |
| GB Sciences, Inc. | -1.36 Million USD | -1812.935% |
| Alpha Cognition Inc. | -13.77 Million USD | -89.13% |
| HST Global, Inc. | -146.21 Thousand USD | -17715.471% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -1384.41% |
| Halberd Corporation | -79.67 Thousand USD | -32592.404% |
| Enzolytics Inc. | -2.17 Million USD | -1096.601% |
| Agentix Corp. | -1.37 Million USD | -1795.488% |
| Resverlogix Corp. | -3.61 Million USD | -621.551% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | -721.331% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -295.05 Million USD | 91.172% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 26679.592% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 476.166% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | -555.627% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | -760.768% |
| AVAX Technologies, Inc. | -6.41 Million USD | -306.134% |
| Zenith Capital Corp. | -10.59 Million USD | -145.829% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -111972.971% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | -528.278% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -42996.852% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -1199.078% |
| Kadimastem Ltd | -3.3 Million USD | -687.568% |
| Helix BioMedix, Inc. | -1.05 Million USD | -2366.534% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -5801.638% |
| LadRx Corporation | 400.44 Thousand USD | 6604.796% |
| Cell Source, Inc. | -5.32 Million USD | -389.513% |
| Regen BioPharma, Inc. | 1.02 Million USD | 2644.973% |
| NovAccess Global Inc. | -4.76 Million USD | -446.173% |
| Affymax, Inc. | -14.42 Million USD | -80.588% |
| Itoco Inc. | -1.86 Million USD | -1293.69% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | -486.332% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -1460.695% |
| Mobile Lads Corp. | -2.26 Million USD | -1050.89% |
| CytoDyn Inc. | -49.84 Million USD | 47.738% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -32858.384% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -11318.201% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -2666.564% |
| SYBLEU INC | -180.3 Thousand USD | -14346.712% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -1515.142% |
| International Stem Cell Corporation | -131 Thousand USD | -19783.969% |
| Bioxytran, Inc. | -4.28 Million USD | -508.598% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -47895.283% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | -929.465% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | 45.815% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | -1132.167% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -3235.694% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | -722.222% |
| Neutra Corp. | -233.46 Thousand USD | -11057.133% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -28.372% |
| PureTech Health plc | -65.69 Million USD | 60.351% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | -22.484% |
| IXICO plc | -1.17 Million USD | -2111.205% |
| IntelGenx Technologies Corp. | -9.92 Million USD | -162.395% |
| Gelesis Holdings, Inc. | -57.12 Million USD | 54.404% |
| CSL Limited | 2.64 Billion USD | 100.986% |
| Cellectis S.A. | -103.17 Million USD | 74.753% |